RE:RE:Good News Canadian Biotech StoryNot for me personally but Thtx long term shareholders have had a lot more potential for success that the scenario you are talking about. They have approved drugs ect and a very promising pipeline, its managements inability to learn from past failures marketing their potential and current valuation gap from other companies far behind them now in the process. Not to mention but I personally feel they have left a lot out there at shareholders expense due to their stubbornness to make changes from past mistakes in marketing and selling the story. Simple things like pr's, timing of news, and transparency